Estimate Recalculated Nov 1, 2024 10:35AM EST
Scott Dunseth Myers has an estimated net worth of $4.43 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., DYNAVAX TECHNOLOGIES CORP, Harpoon Therapeutics, Inc., SELECTA BIOSCIENCES INC, Trillium Therapeutics Inc., AMAG PHARMACEUTICALS, INC., Viridian Therapeutics, Inc.\DE, and DOV PHARMACEUTICAL INC.
Scott Dunseth Myers's CIK is 0001356256
2023 was Scott Dunseth Myers's most active year for acquiring shares with 12 total transactions. Scott Dunseth Myers's most active month to acquire stocks was the month of April. 2018 was Scott Dunseth Myers's most active year for disposing of shares, totalling 10 transactions. Scott Dunseth Myers's most active month to dispose stocks was the month of February. 2023 saw Scott Dunseth Myers paying a total of $261,803.25 for 1,502,213 shares, this is the most they've acquired in one year. In 2023 Scott Dunseth Myers cashed out on 207,500 shares for a total of $81,375.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!